Click for best price
Menopausal Disorder Treatment Market Size, Share 2024
The global Menopausal Disorder Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Menopausal Disorder Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Menopausal Disorder Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Menopausal Disorder Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Hormonal Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Menopausal Disorder Treatment include Abbott, Abbvie, AstraZeneca, Besins Healthcare, Dr. Reddy?s Laboratories, Duchesnay USA, Eli Lilly and Company, F. Hoffmann-La Roche and Fervent Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Menopausal Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menopausal Disorder Treatment. This report contains market size and forecasts of Menopausal Disorder Treatment in global, including the following market information:
Global Menopausal Disorder Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Menopausal Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Menopausal Disorder Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Menopausal Disorder Treatment Market Segment Percentages, by Type, 2023 (%)
- Hormonal Therapy
- Non-Hormonal Therapy
Global Menopausal Disorder Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Menopausal Disorder Treatment Market Segment Percentages, by Application, 2023 (%)
- Hospital
- Specialty Clinics
- Laboratories
- Others
Global Menopausal Disorder Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Menopausal Disorder Treatment Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Menopausal Disorder Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Menopausal Disorder Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Abbvie
- AstraZeneca
- Besins Healthcare
- Dr. Reddy?s Laboratories
- Duchesnay USA
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Fervent Pharmaceuticals
- GSK
- Ipsen Pharma
- Johnson & Johnson Private Limited
- KaNDy Therapeutics
- Merck & Co
- Mithra Pharmaceuticals
- Mylan N.V.
- Novartis AG
- Novo Nordisk A/S
- Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Menopausal Disorder Treatment, market overview.
Chapter 2: Global Menopausal Disorder Treatment market size in revenue.
Chapter 3: Detailed analysis of Menopausal Disorder Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Menopausal Disorder Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Menopausal Disorder Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Menopausal Disorder Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Menopausal Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Menopausal Disorder Treatment Overall Market Size
2.1 Global Menopausal Disorder Treatment Market Size: 2023 VS 2030
2.2 Global Menopausal Disorder Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Menopausal Disorder Treatment Players in Global Market
3.2 Top Global Menopausal Disorder Treatment Companies Ranked by Revenue
3.3 Global Menopausal Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Menopausal Disorder Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Menopausal Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Menopausal Disorder Treatment Players in Global Market
3.6.1 List of Global Tier 1 Menopausal Disorder Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Menopausal Disorder Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Menopausal Disorder Treatment Market Size Markets, 2023 & 2030
4.1.2 Hormonal Therapy
4.1.3 Non-Hormonal Therapy
4.2 By Type - Global Menopausal Disorder Treatment Revenue & Forecasts
4.2.1 By Type - Global Menopausal Disorder Treatment Revenue, 2019-2024
4.2.2 By Type - Global Menopausal Disorder Treatment Revenue, 2025-2030
4.2.3 By Type - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Menopausal Disorder Treatment Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Specialty Clinics
5.1.4 Laboratories
5.1.5 Others
5.2 By Application - Global Menopausal Disorder Treatment Revenue & Forecasts
5.2.1 By Application - Global Menopausal Disorder Treatment Revenue, 2019-2024
5.2.2 By Application - Global Menopausal Disorder Treatment Revenue, 2025-2030
5.2.3 By Application - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Menopausal Disorder Treatment Market Size, 2023 & 2030
6.2 By Region - Global Menopausal Disorder Treatment Revenue & Forecasts
6.2.1 By Region - Global Menopausal Disorder Treatment Revenue, 2019-2024
6.2.2 By Region - Global Menopausal Disorder Treatment Revenue, 2025-2030
6.2.3 By Region - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Menopausal Disorder Treatment Revenue, 2019-2030
6.3.2 US Menopausal Disorder Treatment Market Size, 2019-2030
6.3.3 Canada Menopausal Disorder Treatment Market Size, 2019-2030
6.3.4 Mexico Menopausal Disorder Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Menopausal Disorder Treatment Revenue, 2019-2030
6.4.2 Germany Menopausal Disorder Treatment Market Size, 2019-2030
6.4.3 France Menopausal Disorder Treatment Market Size, 2019-2030
6.4.4 U.K. Menopausal Disorder Treatment Market Size, 2019-2030
6.4.5 Italy Menopausal Disorder Treatment Market Size, 2019-2030
6.4.6 Russia Menopausal Disorder Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Menopausal Disorder Treatment Market Size, 2019-2030
6.4.8 Benelux Menopausal Disorder Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Menopausal Disorder Treatment Revenue, 2019-2030
6.5.2 China Menopausal Disorder Treatment Market Size, 2019-2030
6.5.3 Japan Menopausal Disorder Treatment Market Size, 2019-2030
6.5.4 South Korea Menopausal Disorder Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Menopausal Disorder Treatment Market Size, 2019-2030
6.5.6 India Menopausal Disorder Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Menopausal Disorder Treatment Revenue, 2019-2030
6.6.2 Brazil Menopausal Disorder Treatment Market Size, 2019-2030
6.6.3 Argentina Menopausal Disorder Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Menopausal Disorder Treatment Revenue, 2019-2030
6.7.2 Turkey Menopausal Disorder Treatment Market Size, 2019-2030
6.7.3 Israel Menopausal Disorder Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Menopausal Disorder Treatment Market Size, 2019-2030
6.7.5 UAE Menopausal Disorder Treatment Market Size, 2019-2030
7 Menopausal Disorder Treatment Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Menopausal Disorder Treatment Major Product Offerings
7.1.4 Abbott Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.1.5 Abbott Key News & Latest Developments
7.2 Abbvie
7.2.1 Abbvie Company Summary
7.2.2 Abbvie Business Overview
7.2.3 Abbvie Menopausal Disorder Treatment Major Product Offerings
7.2.4 Abbvie Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.2.5 Abbvie Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Menopausal Disorder Treatment Major Product Offerings
7.3.4 AstraZeneca Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Besins Healthcare
7.4.1 Besins Healthcare Company Summary
7.4.2 Besins Healthcare Business Overview
7.4.3 Besins Healthcare Menopausal Disorder Treatment Major Product Offerings
7.4.4 Besins Healthcare Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.4.5 Besins Healthcare Key News & Latest Developments
7.5 Dr. Reddy?s Laboratories
7.5.1 Dr. Reddy?s Laboratories Company Summary
7.5.2 Dr. Reddy?s Laboratories Business Overview
7.5.3 Dr. Reddy?s Laboratories Menopausal Disorder Treatment Major Product Offerings
7.5.4 Dr. Reddy?s Laboratories Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.5.5 Dr. Reddy?s Laboratories Key News & Latest Developments
7.6 Duchesnay USA
7.6.1 Duchesnay USA Company Summary
7.6.2 Duchesnay USA Business Overview
7.6.3 Duchesnay USA Menopausal Disorder Treatment Major Product Offerings
7.6.4 Duchesnay USA Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.6.5 Duchesnay USA Key News & Latest Developments
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Menopausal Disorder Treatment Major Product Offerings
7.7.4 Eli Lilly and Company Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.7.5 Eli Lilly and Company Key News & Latest Developments
7.8 F. Hoffmann-La Roche
7.8.1 F. Hoffmann-La Roche Company Summary
7.8.2 F. Hoffmann-La Roche Business Overview
7.8.3 F. Hoffmann-La Roche Menopausal Disorder Treatment Major Product Offerings
7.8.4 F. Hoffmann-La Roche Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.8.5 F. Hoffmann-La Roche Key News & Latest Developments
7.9 Fervent Pharmaceuticals
7.9.1 Fervent Pharmaceuticals Company Summary
7.9.2 Fervent Pharmaceuticals Business Overview
7.9.3 Fervent Pharmaceuticals Menopausal Disorder Treatment Major Product Offerings
7.9.4 Fervent Pharmaceuticals Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.9.5 Fervent Pharmaceuticals Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Menopausal Disorder Treatment Major Product Offerings
7.10.4 GSK Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.10.5 GSK Key News & Latest Developments
7.11 Ipsen Pharma
7.11.1 Ipsen Pharma Company Summary
7.11.2 Ipsen Pharma Business Overview
7.11.3 Ipsen Pharma Menopausal Disorder Treatment Major Product Offerings
7.11.4 Ipsen Pharma Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.11.5 Ipsen Pharma Key News & Latest Developments
7.12 Johnson & Johnson Private Limited
7.12.1 Johnson & Johnson Private Limited Company Summary
7.12.2 Johnson & Johnson Private Limited Business Overview
7.12.3 Johnson & Johnson Private Limited Menopausal Disorder Treatment Major Product Offerings
7.12.4 Johnson & Johnson Private Limited Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.12.5 Johnson & Johnson Private Limited Key News & Latest Developments
7.13 KaNDy Therapeutics
7.13.1 KaNDy Therapeutics Company Summary
7.13.2 KaNDy Therapeutics Business Overview
7.13.3 KaNDy Therapeutics Menopausal Disorder Treatment Major Product Offerings
7.13.4 KaNDy Therapeutics Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.13.5 KaNDy Therapeutics Key News & Latest Developments
7.14 Merck & Co
7.14.1 Merck & Co Company Summary
7.14.2 Merck & Co Business Overview
7.14.3 Merck & Co Menopausal Disorder Treatment Major Product Offerings
7.14.4 Merck & Co Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.14.5 Merck & Co Key News & Latest Developments
7.15 Mithra Pharmaceuticals
7.15.1 Mithra Pharmaceuticals Company Summary
7.15.2 Mithra Pharmaceuticals Business Overview
7.15.3 Mithra Pharmaceuticals Menopausal Disorder Treatment Major Product Offerings
7.15.4 Mithra Pharmaceuticals Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.15.5 Mithra Pharmaceuticals Key News & Latest Developments
7.16 Mylan N.V.
7.16.1 Mylan N.V. Company Summary
7.16.2 Mylan N.V. Business Overview
7.16.3 Mylan N.V. Menopausal Disorder Treatment Major Product Offerings
7.16.4 Mylan N.V. Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.16.5 Mylan N.V. Key News & Latest Developments
7.17 Novartis AG
7.17.1 Novartis AG Company Summary
7.17.2 Novartis AG Business Overview
7.17.3 Novartis AG Menopausal Disorder Treatment Major Product Offerings
7.17.4 Novartis AG Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.17.5 Novartis AG Key News & Latest Developments
7.18 Novo Nordisk A/S
7.18.1 Novo Nordisk A/S Company Summary
7.18.2 Novo Nordisk A/S Business Overview
7.18.3 Novo Nordisk A/S Menopausal Disorder Treatment Major Product Offerings
7.18.4 Novo Nordisk A/S Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.18.5 Novo Nordisk A/S Key News & Latest Developments
7.19 Pfizer
7.19.1 Pfizer Company Summary
7.19.2 Pfizer Business Overview
7.19.3 Pfizer Menopausal Disorder Treatment Major Product Offerings
7.19.4 Pfizer Menopausal Disorder Treatment Revenue in Global Market (2019-2024)
7.19.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Menopausal Disorder Treatment Market Opportunities & Trends in Global Market
Table 2. Menopausal Disorder Treatment Market Drivers in Global Market
Table 3. Menopausal Disorder Treatment Market Restraints in Global Market
Table 4. Key Players of Menopausal Disorder Treatment in Global Market
Table 5. Top Menopausal Disorder Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Menopausal Disorder Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Menopausal Disorder Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Menopausal Disorder Treatment Product Type
Table 9. List of Global Tier 1 Menopausal Disorder Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Menopausal Disorder Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Menopausal Disorder Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Menopausal Disorder Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Menopausal Disorder Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Menopausal Disorder Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Menopausal Disorder Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Menopausal Disorder Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Menopausal Disorder Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Menopausal Disorder Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Menopausal Disorder Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Menopausal Disorder Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Menopausal Disorder Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Menopausal Disorder Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Menopausal Disorder Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Menopausal Disorder Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Company Summary
Table 31. Abbott Menopausal Disorder Treatment Product Offerings
Table 32. Abbott Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Key News & Latest Developments
Table 34. Abbvie Company Summary
Table 35. Abbvie Menopausal Disorder Treatment Product Offerings
Table 36. Abbvie Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Abbvie Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Menopausal Disorder Treatment Product Offerings
Table 40. AstraZeneca Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Besins Healthcare Company Summary
Table 43. Besins Healthcare Menopausal Disorder Treatment Product Offerings
Table 44. Besins Healthcare Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Besins Healthcare Key News & Latest Developments
Table 46. Dr. Reddy?s Laboratories Company Summary
Table 47. Dr. Reddy?s Laboratories Menopausal Disorder Treatment Product Offerings
Table 48. Dr. Reddy?s Laboratories Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Dr. Reddy?s Laboratories Key News & Latest Developments
Table 50. Duchesnay USA Company Summary
Table 51. Duchesnay USA Menopausal Disorder Treatment Product Offerings
Table 52. Duchesnay USA Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Duchesnay USA Key News & Latest Developments
Table 54. Eli Lilly and Company Company Summary
Table 55. Eli Lilly and Company Menopausal Disorder Treatment Product Offerings
Table 56. Eli Lilly and Company Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Eli Lilly and Company Key News & Latest Developments
Table 58. F. Hoffmann-La Roche Company Summary
Table 59. F. Hoffmann-La Roche Menopausal Disorder Treatment Product Offerings
Table 60. F. Hoffmann-La Roche Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. F. Hoffmann-La Roche Key News & Latest Developments
Table 62. Fervent Pharmaceuticals Company Summary
Table 63. Fervent Pharmaceuticals Menopausal Disorder Treatment Product Offerings
Table 64. Fervent Pharmaceuticals Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Fervent Pharmaceuticals Key News & Latest Developments
Table 66. GSK Company Summary
Table 67. GSK Menopausal Disorder Treatment Product Offerings
Table 68. GSK Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. GSK Key News & Latest Developments
Table 70. Ipsen Pharma Company Summary
Table 71. Ipsen Pharma Menopausal Disorder Treatment Product Offerings
Table 72. Ipsen Pharma Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 73. Ipsen Pharma Key News & Latest Developments
Table 74. Johnson & Johnson Private Limited Company Summary
Table 75. Johnson & Johnson Private Limited Menopausal Disorder Treatment Product Offerings
Table 76. Johnson & Johnson Private Limited Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 77. Johnson & Johnson Private Limited Key News & Latest Developments
Table 78. KaNDy Therapeutics Company Summary
Table 79. KaNDy Therapeutics Menopausal Disorder Treatment Product Offerings
Table 80. KaNDy Therapeutics Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 81. KaNDy Therapeutics Key News & Latest Developments
Table 82. Merck & Co Company Summary
Table 83. Merck & Co Menopausal Disorder Treatment Product Offerings
Table 84. Merck & Co Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 85. Merck & Co Key News & Latest Developments
Table 86. Mithra Pharmaceuticals Company Summary
Table 87. Mithra Pharmaceuticals Menopausal Disorder Treatment Product Offerings
Table 88. Mithra Pharmaceuticals Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 89. Mithra Pharmaceuticals Key News & Latest Developments
Table 90. Mylan N.V. Company Summary
Table 91. Mylan N.V. Menopausal Disorder Treatment Product Offerings
Table 92. Mylan N.V. Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 93. Mylan N.V. Key News & Latest Developments
Table 94. Novartis AG Company Summary
Table 95. Novartis AG Menopausal Disorder Treatment Product Offerings
Table 96. Novartis AG Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 97. Novartis AG Key News & Latest Developments
Table 98. Novo Nordisk A/S Company Summary
Table 99. Novo Nordisk A/S Menopausal Disorder Treatment Product Offerings
Table 100. Novo Nordisk A/S Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 101. Novo Nordisk A/S Key News & Latest Developments
Table 102. Pfizer Company Summary
Table 103. Pfizer Menopausal Disorder Treatment Product Offerings
Table 104. Pfizer Menopausal Disorder Treatment Revenue (US$, Mn) & (2019-2024)
Table 105. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Menopausal Disorder Treatment Segment by Type in 2023
Figure 2. Menopausal Disorder Treatment Segment by Application in 2023
Figure 3. Global Menopausal Disorder Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Menopausal Disorder Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Menopausal Disorder Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Menopausal Disorder Treatment Revenue in 2023
Figure 8. By Type - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Menopausal Disorder Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Menopausal Disorder Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 16. US Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 28. China Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Menopausal Disorder Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Menopausal Disorder Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abbvie Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. AstraZeneca Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Besins Healthcare Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Dr. Reddy?s Laboratories Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Duchesnay USA Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Eli Lilly and Company Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. F. Hoffmann-La Roche Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Fervent Pharmaceuticals Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. GSK Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Ipsen Pharma Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Johnson & Johnson Private Limited Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. KaNDy Therapeutics Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Merck & Co Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Mithra Pharmaceuticals Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Mylan N.V. Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Novartis AG Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Novo Nordisk A/S Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Pfizer Menopausal Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
